Our study also demonstrated that c-myc acts as a transcriptional repressor to inhibit miR-16 expression in glioma, and the low-levels of intracellular miR-16 results in glioma growth through increasing Cyclin D1 and Cyclin E1 expression. The gene discussed is CCND1; the disease is glioma.